AstraZeneca publishes vaccines contract with EU after vaccine row

The European Commission published its contract with drugmaker AstraZeneca today after a row over the delay in the bloc getting vaccines.

Commission chief spokesperson Eric Mamer said some information is redacted, however.

However the redacted contract, which does not reveal how much was paid, states that “AstraZeneca has committed to use its Best Reasonable Efforts… to build capacity to manufacture 300 million Doses of  the Vaccine, at no profit and no loss to AstraZeneca, at the total cost currently estimated to be [redacted] Euros for distribution within the EU, with an option for the Commission, acting on behalf of the Participating  Member States, to order an additional 100 million Doses.”